Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease NAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05029583
What this trial is testing

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Who this might be right for
Nonalcoholic SteatohepatitisType 2 Diabetes
LMC Diabetes & Endocrinology Ltd. 5,000
Testing effectiveness (Phase 2)Study completedNCT00633282
What this trial is testing

Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Xin Gao 184
Not applicableStudy completedNCT05550688
What this trial is testing

Weight Gain After Smoking Cessation and NAFLD

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Ningbo No. 1 Hospital 12,941
Not applicableLooking for participantsNCT06939569
What this trial is testing

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Inflammatory Bowel Disease (IBD)Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital 337
Not applicableStudy completedNCT03528707
What this trial is testing

Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD

Who this might be right for
Type2 DiabetesNAFLDProbiotic+1 more
Bogomolets National Medical University 48
Not applicableUnknownNCT05257200
What this trial is testing

Gut Permeability and Bariatric-metabolic Surgery

Who this might be right for
NASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability
Medical University of Vienna 125
Not applicableUnknownNCT04969744
What this trial is testing

Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Guy's and St Thomas' NHS Foundation Trust 36
Not applicableStudy completedNCT05231564
What this trial is testing

Hybrid Training and Middle Age

Who this might be right for
Women's HealthHybrid TrainingMiddle Aged+2 more
University of Sistan and Baluchestan 15
Not applicableStudy completedNCT04130321
What this trial is testing

Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans

Who this might be right for
OverweightMicrotiaEndotoxemia+3 more
Laval University 35
Not applicableUnknownNCT04081571
What this trial is testing

Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian

Who this might be right for
NAFLDInsulin ResistanceHepatic Steatosis
Cairo University 1,080
Not applicableUnknownNCT03819283
What this trial is testing

NASH and Coronary Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Assistance Publique - Hôpitaux de Paris 260
Post-approval studies (Phase 4)Study completedNCT04910178
What this trial is testing

Follow-up of NAFLD Patients With MRI-PDFF

Who this might be right for
Diabetes Type 2NAFLD
Asmaa Abdelfattah Elsayed 80
Very early researchStudy completedNCT01940263
What this trial is testing

Purified Anthocyanin and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Shaoguan University 63
Post-approval studies (Phase 4)Looking for participantsNCT05644717
What this trial is testing

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Who this might be right for
Liver FatLiver FibrosisGlycemic Control+3 more
Getz Pharma 164
Testing effectiveness (Phase 2)Study completedNCT03449446
What this trial is testing

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 395
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Testing effectiveness (Phase 2)Study completedNCT05397379
What this trial is testing

A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Sunshine Lake Pharma Co., Ltd. 68
Not applicableLooking for participantsNCT07692438
What this trial is testing

Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver Disease NAFLDDyslipidemia+1 more
Taipei Medical University 60
Not applicableLooking for participantsNCT02422238
What this trial is testing

Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Maastricht University Medical Center 500
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Next Page